🔥 Trending Sun Pharma Share Price: Latest Updates and Performance Analysis

Sun Pharmaceutical Industries Limited (SUNPHARMA) is a major player in the pharmaceutical sector. As of recent reports, its share price and performance have shown some notable trends.

Current Share Price and Recent Movements

As of July 15, 2026, 10:03 PM IST, Sun Pharmaceutical Industries Limited's share price was ₹1,954.15, marking a +0.72% increase or +₹14.00 from its previous close ⁸.

On August 4, 2026, the company's shares fell 2% in early trade ¹. However, analysts have maintained a price target of ₹2,039.91 for Sun Pharmaceutical Industries ⁶.

Recent Financial Performance (Q1 FY27)

Sun Pharma reported strong financial results for the first quarter of the fiscal year 2027 (Q1 FY27), despite some sector-specific challenges:

• Net Profit: The company's net profit rose by 27% year-on-year (YoY) to ₹2,895 crore ⁹¹⁰. This growth was primarily driven by strong performance in India and its innovative medicines business ⁹¹⁰.
• Revenue: Revenue for Q1 FY27 climbed by 10.5% to ₹15,300 crore ¹⁰. Consolidated net sales were reported at ₹15,299.88 crore, showing a 10.46% increase YoY ¹.
• US Generics Business: Despite the overall positive results, the US generics business continued to experience weakness, which weighed on growth ⁹¹⁰.

Other Key Metrics and Analyst Views

• Dividend Yield: Sun Pharma's trailing dividend yield is 0.9%, which is lower than the top quartile of Indian dividend payers (1.5%) but higher than the average of its industry peers (0.7%) ⁶.
• Block Trade: A significant block trade occurred on the NSE, involving approximately 214,109 shares at a price of ₹1,867.70 per share, totaling ₹39.99 crores ⁵.
• Analyst Recommendations: Motilal Oswal has given a "Buy" rating for Sun Pharma with a target of ₹2,310 ¹.

Investors should monitor the company's performance, especially considering the mixed signals from the strong Q1 results and the ongoing challenges in the US generics market.